Cargando…

Alzheimer's disease medication and outcomes of hospitalisation among patients with dementia

AIMS: The use of Alzheimer disease medication for the treatment of dementia symptoms has shown significant benefits with regards to functional and cognitive outcomes as well as nursing home placement (NHP) and mortality. Hospitalisations in these patient groups are characterised by extended length o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Möllers, T., Perna, L., Stocker, H., Ihle, P., Schubert, I., Schöttker, B., Frölich, L., Bauer, J., Brenner, H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060969/ https://www.ncbi.nlm.nih.gov/pubmed/31722770 http://dx.doi.org/10.1017/S2045796019000702

Ejemplares similares

Prediction of clinical diagnosis of Alzheimer’s disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years
por: Stocker, H., et al.
Publicado: (2020)

Correction: Prediction of clinical diagnosis of Alzheimer’s disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years
por: Stocker, H., et al.
Publicado: (2021)

The genetic risk of Alzheimer’s disease beyond APOE ε4: systematic review of Alzheimer’s genetic risk scores
por: Stocker, Hannah, et al.
Publicado: (2018)

Association of Kidney Function With Development of Alzheimer Disease and Other Dementias and Dementia-Related Blood Biomarkers
por: Stocker, Hannah, et al.
Publicado: (2023)

Genetic predisposition, Aβ misfolding in blood plasma, and Alzheimer’s disease
por: Stocker, Hannah, et al.
Publicado: (2021)

Aβ misfolding in blood plasma measured by immuno‐infrared‐sensor as an age‐independent risk marker of Alzheimer's disease
por: Möllers, Tobias, et al.
Publicado: (2021)

Alzheimer’s polygenic risk scores, APOE, Alzheimer’s disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years
por: Stocker, Hannah, et al.
Publicado: (2023)

Aβ misfolding in blood plasma is inversely associated with body mass index even in middle adulthood
por: Möllers, Tobias, et al.
Publicado: (2021)

Association of the inflammation-related proteome with dementia development at older age: results from a large, prospective, population-based cohort study
por: Trares, Kira, et al.
Publicado: (2022)

Long-term low-dose acetylsalicylic use shows protective potential for the development of both vascular dementia and Alzheimer’s disease in patients with coronary heart disease but not in other individuals from the general population: results from two large cohort studies
por: Nguyen, Thi Ngoc Mai, et al.
Publicado: (2022)

Quality of Life as an outcome in Alzheimer's disease and other dementias- obstacles and goals
por: Riepe, Matthias W, et al.
Publicado: (2009)

Comparison of cognitive and neuropsychiatric profiles in hospitalised elderly medical patients with delirium, dementia and comorbid delirium–dementia
por: Leonard, Maeve, et al.
Publicado: (2016)

Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment
por: Lacour, A, et al.
Publicado: (2017)

OPTIMAL MEDICATION MANAGEMENT IN ALZHEIMER’S DISEASE AND DEMENTIA
por: Green, Ariel
Publicado: (2019)

Dementia in the oldest old: Beyond Alzheimer disease
por: Pierce, Aimee L., et al.
Publicado: (2017)

Type 2 diabetes mellitus and cognitive decline in older adults in Germany – results from a population-based cohort
por: Xie, Kun, et al.
Publicado: (2022)

THE ASPREE STUDY: DEMENTIA DUE TO ALZHEIMER’S DISEASE OUTCOMES
por: Shah, Raj C
Publicado: (2019)

Vitamin D Insufficiency May Account for Almost Nine of Ten COVID-19 Deaths: Time to Act. Comment on: “Vitamin D Deficiency and Outcome of COVID-19 Patients”. Nutrients 2020, 12, 2757
por: Brenner, Hermann, et al.
Publicado: (2020)

Frailty is associated with the epigenetic clock but not with telomere length in a German cohort
por: Breitling, Lutz Philipp, et al.
Publicado: (2016)

Subjective cognitive complaints and blood biomarkers of neurodegenerative diseases: a longitudinal cohort study
por: Perna, Laura, et al.
Publicado: (2023)

Identifying patterns of potentially preventable hospitalisations in people living with dementia
por: Engel, Lidia, et al.
Publicado: (2022)

Dementia / Alzheimer's Disease
por: Lindsay, Joan, et al.
Publicado: (2004)

Diverse perspectives on hospitalisation events among people with dementia: protocol for a multisite qualitative study
por: Gilmore-Bykovskyi, Andrea, et al.
Publicado: (2021)

Vitamin D and the risk of dementia and Alzheimer disease
por: Littlejohns, Thomas J., et al.
Publicado: (2014)

Something is amiss in Denmark: A comparison of preventable hospitalisations and readmissions for chronic medical conditions in the Danish Healthcare system and Kaiser Permanente
por: Schiøtz, Michaela, et al.
Publicado: (2011)

Subjective mental health, incidence of depressive symptoms in later life, and the role of epigenetics: results from two longitudinal cohort studies
por: Perna, Laura, et al.
Publicado: (2020)

Gender Disparities in Anti-dementia Medication Use among Older Adults: Health Equity Considerations and Management of Alzheimer's Disease and Related Dementias
por: Lu, Z. Kevin, et al.
Publicado: (2021)

Measurement to improve care and outcomes for persons with Alzheimer's disease and dementia
por: Zimmerman, Sheryl, et al.
Publicado: (2022)

Impact of frailty on the performance of the National Early Warning Score 2 to predict poor outcome in patients hospitalised due to COVID-19
por: Rønningen, Peter Selmer, et al.
Publicado: (2023)

Views on Firearm Safety Among Caregivers of People With Alzheimer Disease and Related Dementias
por: Betz, Marian E., et al.
Publicado: (2020)

Predictors of the Progression of Dementia Severity in Brazilian Patients with Alzheimer's Disease and Vascular Dementia
por: Chaves, Márcia L., et al.
Publicado: (2010)

Vitamin D(3) for reducing mortality from cancer and other outcomes before, during and beyond the COVID‐19 pandemic: A plea for harvesting low‐hanging fruit
por: Brenner, Hermann, et al.
Publicado: (2022)

Gender disparities in diabetes and coronary heart disease medication among patients with type 2 diabetes: results from the DIANA study
por: Krämer, Heike U, et al.
Publicado: (2012)

THE EPIDEMIOLOGY OF ALZHEIMER’S DISEASE AND RELATED DEMENTIAS AMONG ARAB AMERICANS
por: Dallo, Florence, et al.
Publicado: (2019)

Multimodal deep learning for Alzheimer’s disease dementia assessment
por: Qiu, Shangran, et al.
Publicado: (2022)

Krankheitsmodifizierende Therapieansätze bei Alzheimer-Krankheit
por: Frölich, Lutz, et al.
Publicado: (2021)

Frontotemporal dementia to Alzheimer's disease
por: Silveri, Maria Caterina
Publicado: (2007)

Vascular and Alzheimer Disease in Dementia
por: Strandberg, Timo E., et al.
Publicado: (2020)

Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia
por: Frölich, Lutz, et al.
Publicado: (2017)

Identification of a Cascade of Changes in Activities of Daily Living Preceding Short-Term Clinical Deterioration in Mild Alzheimer’s Disease Dementia via Lead-Lag Analysis
por: Fuentes, Manuel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1jd02cmrik4vlu4afleapdbcd8